Drug
124i Humanized 3f8
124i Humanized 3f8: highest development phase Not Applicable, developed by Y-mAbs Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- Y-mAbs Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| 124I-Humanized 3F8 NCT02307630 | Not Applicable | Melanoma |
Latest
No recent events.
Follow 124i Humanized 3f8 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.